Showing results (21-30 of 134) with videos related to
Sort By:
Pageof 14
Developments in Biological Standardization|January 1, 1983
Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccinesS J Cryz, E Fürer, R GermanierJournal of Clinical Microbiology|July 1, 1982
Development of an enzyme-linked immunosorbent assay for studying Vibrio cholerae cell surface antigensS J Cryz, E Fürer, R GermanierFEMS Immunology and Medical Microbiology|June 1, 1993
Feasibility of prophylaxis and therapy against gram-negative infections by human monoclonal antibodiesA B Lang, E Fürer, S J CryzVaccine|October 1, 1996
A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humansS J Cryz, J U Que, R GlückMolecular Microbiology|March 1, 1996
Expression of Shigella sonnei lipopolysaccharide in Vibrio choleraeJ F Viret, S J Cryz, D FavreInfection and Immunity|September 1, 1996
Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139D Favre, S J Cryz, J F ViretInfection and Immunity|February 1, 1996
Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharideD Favre, S J Cryz, J F ViretInfection and Immunity|January 11, 1991
Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccineS J Cryz, E Fürer, J U QueSchweizerische Medizinische Wochenschrift|April 2, 1988
[Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials]S J Cryz, E Fürer, M M LevineInfection and Immunity|July 1, 1988
Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humansS J Cryz, J C Sadoff, E FürerPageof 14